NDAORALTABLET, EXTENDED RELEASE
Approved
Jun 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
3/8 — Basic
MEASURIN (aspirin) by Bayer is [acetylsalicylic acid (asa)] inhibits prostaglandin synthesis resulting in inhibition of platelet aggregation for their lifespan of about 7-10 days. First approved in 1965.
Drug data last refreshed 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MEASURIN (aspirin) is an oral extended-release tablet containing acetylsalicylic acid (ASA) that irreversibly inhibits platelet aggregation by binding to cyclooxygenase-1 (COX-1) and blocking thromboxane A2 synthesis. It is indicated for coronary artery disease, stroke, acute coronary syndrome, and migraine prevention. The drug has been the standard antiplatelet therapy for cardiovascular protection for decades.
LOE Approaching
As LOE approaches, the MEASURIN team is likely consolidating resources and shifting focus to defending market share against newer antiplatelet and migraine-specific agents with smaller, specialized teams.
Mechanism of Action
[acetylsalicylic acid (ASA)] inhibits prostaglandin synthesis resulting in inhibition of platelet aggregation for their lifespan of about 7-10 days. The acetyl group of aspirin binds with a serine residue of cyclooxygenase-1 (COX-1) , resulting in irreversible inactivation of the enzyme. Inhibition…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Measuring Local Potentials in PFA. MULTI PFA (EU)
Started Apr 2026
30 enrolled
Atrial Fibrillation (AF)
Measuring Outcomes With Validated Exercise
Started Dec 2025
54 enrolled
Physical Activity
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
Started Nov 2025
96 enrolled
Drug Drug Interaction (DDI)
Exploring and Measuring the Impact of Steroids in Children and Young People
Started Nov 2025
70 enrolled
Rheumatic DiseasesRheumatic DisorderRheumatologic Conditions (JRA,Lupus)
Clinical Investigation Measuring the Long Term Clinical Performance and Safety of Biodentine™ XP in Patients Treated for Coronal Restorative or Endodontic Dental Indications.
Started Oct 2025
275 enrolled
Dental Restoration, PermanentDental RestorationsEndodontic Treatment
Worked on MEASURIN at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.